Cancer Diagnostics Market is Expected to Reach Approximately $ 250.3 Bn By 2026

0
17

Global Cancer Diagnostics Market Size is anticipated to grow at 7.2 % CAGR during the forecast period and reach around US$ 250.3 Billion by 2026.

Recent study titled, Cancer Diagnostics Market By Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 – 2026 which covers clear verifiable examination and lights up feature components and examples that give an extensive picture of the business.

The Cancer Diagnostics Market Industry Report is an in depth study analyzing the current state of the Cancer Diagnostics Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Cancer Diagnostics Market provides analysis of China market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in China market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Cancer Diagnostics Market also discusses the opportunity areas for investors.

The study provides a decisive view of the market by segmenting it in terms of form and application. The segment has been analyzed based on present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1144

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

Market Participants:

Collaborative and independent activities driven by governments and organizations are endeavouring to raise awareness about the advantages of early malignant growth detection. Also, cancer research organizations, alongside public and private elements, are contributing vigorously on research undertakings to launch progressed analytic or diagnostic devices in the market, which are fit for diagnosing the ailment much before the symptoms appear. Main enterprises working in the global cancer diagnostics market are Hologic, Inc.; GE Healthcare; Koninklijke Philips N.V.; Abbott; Illumina, Inc.; Hoffmann-La Roche Ltd.; Becton Dickinson & Company; and Siemens Healthcare GmbH.

The Major Market Segments of Global Cancer Diagnostics Market are as below:

Market Segmentation

Market By Type

  • Laboratory Tests
  • Genetic Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others (barium enema)

Market By Application

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America ruled the industry by capturing the biggest revenue share offer of 43.0% in 2018. Nearness of various biotechnology just as medicinal gadget organizations in the locale is one of the prime elements driving the diagnostics sector in the region. North America is relied upon to proceed with its lead all through the estimate time frame inferable from elements, for example, more prominent subsidizing accessible for research and development projects and high reception of cutting edge innovations. Asia Pacific is relied upon to show the most astounding development sooner rather than later because of quality of a substantial patient pool, accessibility of skilled experts at a relatively lower cost, and a characterized administrative structure favouring expedited product approvals. Besides, the blasting tourism the travel industry in nations, for example, India, China, and Malaysia are relied upon to help demand for oncological screening.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/cancer-diagnostics-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Cancer Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Cancer Diagnostics Market By Type
1.2.2.1. Global Cancer Diagnostics Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Cancer Diagnostics Market Revenue Share By Type in 2017
1.2.2.3. Laboratory Tests
1.2.2.4. Genetic Tests
1.2.2.5. Imaging
1.2.2.6. Endoscopy
1.2.2.7. Biopsy
1.2.2.8. Others (barium enema)
1.2.3. Cancer Diagnostics Market By Application
1.2.3.1. Global Cancer Diagnostics Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Global Cancer Diagnostics Market Revenue Share By Application in 2017
1.2.3.3. Breast Cancer
1.2.3.4. Colorectal Cancer
1.2.3.5. Cervical Cancer
1.2.3.6. Lung Cancer
1.2.3.7. Prostate Cancer
1.2.3.8. Skin Cancer
1.2.3.9. Blood Cancer
1.2.3.10. Kidney Cancer
1.2.3.11. Liver Cancer
1.2.3.12. Pancreatic Cancer
1.2.3.13. Ovarian Cancer
1.2.3.14. Others
1.2.4. Cancer Diagnostics Market by Geography
1.2.4.1. Global Cancer Diagnostics Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Cancer Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Cancer Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Cancer Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Cancer Diagnostics Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Cancer Diagnostics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Cancer Diagnostics Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Cancer Diagnostics Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Cancer Diagnostics Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Cancer Diagnostics Major Manufacturers in 2017

CHAPTER 4. CANCER DIAGNOSTICS MARKET BY TYPE

4.1. Global Cancer Diagnostics Revenue By Type
4.2. Laboratory Tests
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Genetic Tests
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Imaging
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Endoscopy
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Biopsy
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Others (barium enema)
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. CANCER DIAGNOSTICS MARKET BY APPLICATION

5.1. Global Cancer Diagnostics Revenue By Application
5.2. Breast Cancer
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Colorectal Cancer
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Cervical Cancer
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Lung Cancer
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Prostate Cancer
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.7. Skin Cancer
5.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.8. Blood Cancer
5.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.9. Kidney Cancer
5.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.10. Liver Cancer
5.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.11. Pancreatic Cancer
5.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.12. Ovarian Cancer
5.12.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.12.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.13. Others
5.13.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.13.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. NORTH AMERICA CANCER DIAGNOSTICS MARKET BY COUNTRY

6.1. North America Cancer Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. North America Cancer Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Cancer Diagnostics Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 7. EUROPE CANCER DIAGNOSTICS MARKET BY COUNTRY

7.1. Europe Cancer Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Europe Cancer Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CANCER DIAGNOSTICS MARKET BY COUNTRY

8.1. Asia-Pacific Cancer Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Asia-Pacific Cancer Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 9. LATIN AMERICA CANCER DIAGNOSTICS MARKET BY COUNTRY

9.1. Latin America Cancer Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Latin America Cancer Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 10. MIDDLE EAST CANCER DIAGNOSTICS MARKET BY COUNTRY

10.1. Middle East Cancer Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Middle East Cancer Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 11. AFRICA CANCER DIAGNOSTICS MARKET BY COUNTRY

11.1. Africa Cancer Diagnostics Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Africa Cancer Diagnostics Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Hologic, Inc.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. GE Healthcare
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Koninklijke Philips N.V.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Abbott
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Illumina, Inc.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Hoffmann-La Roche Ltd.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Becton Dickinson & Company
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Siemens Healthcare GmbH
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Others
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1144

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

SHARE
Sonia Mehta is a writer from Delhi, India, looking to break into the freelance copywriting field. Sonia covers health and lifestyle news as well as medical research news from around the world.

LEAVE A REPLY

Please enter your comment!
Please enter your name here